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Background: Although emerging evidence suggests that intra-abdominal hyper-
tension (IAH) is a predictor of the development of acute kidney injury (AKI), it
remains unclear whether the presence of IAH is a predictor of prognosis in patients
with AKI. The purpose of this study was to assess whether the presence of IAH could
predict prognosis in critically ill patients with AKI. The prognostic value of urinary
biomarkers was also determined.
Methods: In this prospective observational study, we enrolled 57 patients with
established AKI, who were admitted to the intensive care unit between February
2012 and June 2014. IAH was deﬁned as a sustained elevation in intra-abdominal
pressure of Z12 mmHg, in three consecutive measurements performed daily on
the ﬁrst 3 days. Urinary neutrophil gelatinase-associated lipocalin (NGAL), liver-type
fatty acid-binding protein, and simpliﬁed acute physiology score II score at the time
of admission were also examined.
Results: IAH was observed in 78.9% of patients. The in-hospital mortality was 21.1%,
and renal recovery during hospitalization was achieved in 40.4% of patients.
Although high urinary NGAL [odds ratio (OR), 1.015] and liver-type fatty acid-
binding protein (OR, 1.003) were found to be independent predictors of renal
recovery, IAH was not. High urinary NGAL (OR, 1.003) and a high simpliﬁed acute
physiology score II score (OR, 1.102) were independent predictors of in-hospital
mortality, while IAH or urinary liver-type fatty acid-binding protein was not.
Conclusion: Although IAH is prevalent in critically ill patients with AKI, it did not
predict AKI prognosis. However, urinary NGAL was found to be a useful predictor of
both renal recovery and in-hospital mortality.
Copyright & 2015. The Korean Society of Nephrology. Published by Elsevier. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).15. The Korean Society of Nep
.org/licenses/by-nc-nd/4.0/).
al Medicine, Korea Uni-
m Hospital, 73 Incho-ro,
o).Introduction
Elevated intra-abdominal pressure (IAP) has long been
known to be associated with altered renal function. Bradley
and Bradley [1], more than 60 years ago, found that intra-
abdominal hypertension (IAH) induced by abdominalhrology. Published by Elsevier. This is an open access article under the
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in humans, and suggested that an increase in renal venous
pressure accounted for this change in renal function.
IAH, deﬁned as a pathological increase in IAP, is commonly
found in critically ill patients admitted to intensive care units
(ICUs), and recently has been implicated as a possible cause of
acute kidney injury (AKI). Although several epidemiological
studies indicated that IAH is a useful predictor for AKI develop-
ment [2–5], the predictive value of IAH for renal recovery or
mortality remains unclear.
The purpose of this study was to determine the prevalence
of IAH and to examine whether the presence of IAH during
hospitalization could predict short-term renal recovery or in-
hospital mortality in critically ill patients with established AKI.
The prognostic value of urinary biomarkers, including neutro-
phil gelatinase-associated lipocalin (NGAL) and liver-type fatty
acid-binding protein (L-FABP), in renal recovery or in-hospital
mortality was also investigated.Methods
Patients
This was a single-center, prospective observational study
conducted between February 2012 and June 2014. This study
included 57 consecutive patients who were at least 18 years old
and admitted with a diagnosis of AKI to the medical ICU of the
Korea University Medical Center, Seoul, Korea. Exclusion criteria
were patients with end-stage renal failure who were receiving
maintenance dialysis or had contraindications to the insertion of a
urinary catheter for intravesical pressure measurement, such as
patients with pelvic fracture or urethral injury. The study protocol
was approved by the institutional review board of this center, and
written informed consent was obtained.
Data collection
Data on age, sex, predisposing condition for increased IAP,
length of ICU and hospital stay, and in-hospital mortality were
collected. Patients were followed up until death or discharge from
hospital. The calculation of the Simpliﬁed Acute Physiology Score II
(SAPS II) [6] was based on the worst values recorded on the day of
ICU admission. The primary endpoint was renal recovery from AKI
on Day 7, and the secondary endpoint was in-hospital mortality.
Measurement of IAP
IAP was measured intravesically once a day for the ﬁrst
3 days via a Foley catheter, according to the U-tube manometer
technique [7,8], and the mean value was calculated. The sterile
saline instillation volume was no more than 25 mL, according
to the World Society of the Abdominal Compartment Syn-
drome consensus [9]. IAP was measured in the supine position
at the end of expiration after ensuring that abdominal muscle
contractions were absent. The symphysis pubis was consid-
ered the reference line, and the pressure was expressed in
mmHg (1 mmHg ¼ 1.36 cmH2O) [7–9].
Measurement of urinary NGAL and L-FABP
Urine samples were collected on ICU admission and cen-
trifuged at 2,500 rpm at 41C for 5 minutes. The supernatantswere frozen at 801C until further biomarker analysis. Urinary
NGAL and L-FABP were measured using the NGAL ELISA
(BioPorto, Gentofte, Denmark), and human L-FABP Assay kits
(CMIC Co. Ltd, Tokyo, Japan), respectively, according to the
manufacturer’s instructions.
Case deﬁnition
IAH was deﬁned as a sustained pathological elevation in IAP
of Z12 mmHg, in three consecutive measurements performed
daily on the ﬁrst 3 days, according to the World Society of the
Abdominal Compartment Syndrome consensus [9]. We
deﬁned the following risk factors of IAH [10–13]:(1) Mechanical ventilation, deﬁned as the use of invasive
positive pressure ventilation through an endotracheal
tube or a tracheostomy tube(2) Liver dysfunction, deﬁned as decompensated or com-
pensated cirrhosis or other liver failure with ascites(3) Positive ﬂuid balance, deﬁned as 41.5 L of total
input–output in the initial 72 hours(4) Ileus, deﬁned as abdominal distension or failure of
enteral feeding evidenced by gastric dilatation or gastro-
paresis with gastric residual 41,000 mL in 24 hours(5) Acidosis, deﬁned as an arterial pH of o7.2
(6) Hypothermia, deﬁned as a core temperature of o331C
(7) Polytransfusion, deﬁned as the transfusion of 46
units of packed red cells in 24 hours
(8) Coagulopathy, deﬁned as a platelet count of
o55,000/mm3 or an activated partial thromboplastin
timemore than two times normal or a prothrombin time
of 450% or an international standardized ratio of 41.5(9) Sepsis, deﬁned according to the American–European
consensus conference deﬁnitions(10) Shock, deﬁned as a cardiovascular Sequential Organ
Failure Assessment (SOFA) subscore of 43, i.e., hypoten-
sion requiring dopamine 45 μg/kg/min, or norepinephr-
ine and/or epinephrine o0.1 μg/kg/min.According to the types of changes in IAP during admission,
we categorized these IAP changes into downtrend or uptrend
and ﬂuctuation. Downtrend of IAP was deﬁned as a continuous
decrease in IAP during initial 3 days. AKI was diagnosed and
staged on the day of admission according to the risk–injury–
failure–loss–end-stage kidney disease (RIFLE) criteria. Renal
recovery during hospitalization was deﬁned as a serum crea-
tinine level of o0.45 mg/dL or within 20% above the baseline
value, and without a requirement for dialysis [14] on Day 7
postadmission.
Statistical analysis
All statistical analyses were performed using SPSS ver-
sion 20.0 (IBM Corp, Armonk, NY, USA). Continuous vari-
ables, including IAP and SAPS II score, were expressed as
mean7 standard deviation, calculated using the Student t
test. Skewed data, including urinary NGAL and L-FABP
levels, were expressed as median and interquartile ranges,
and comparisons were assessed using the Mann–Whitney U
test. Categorical variables were expressed as proportions,
and the chi-square test was used for comparisons. Univari-
ate and multivariate logistic regression analyses were
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hospital mortality. A P value of o0.05 was considered
statistically signiﬁcant.Results
Baseline characteristics
Fifty-seven patients were enrolled during the study period.
Their baseline clinical and demographic information is sum-
marized in Table 1. Forty-ﬁve (78.9%) of study patients had IAH
and mean IAP was 22.87 9.6 mmHg. The mean age was
68.77 13.7 years, and 52.6% were men. There were no statis-
tically signiﬁcant differences in baseline and clinical character-
istics, including predisposing conditions for IAH, AKI severity, or
short-term prognosis between patients with or without IAH.
Urinary level of NGAL or L-FABP did not differ either. Exception
was that baseline serum creatinine level was signiﬁcantly lower
in patients with IAH, compared to those with no IAH.
Prediction of renal recovery
Renal recovery, as assessed on Day 7 postadmission, was
observed in 23 (40.4%) patients. Univariate analysis showed
that acidosis, sepsis, severe AKI (failure in RIFLE) (47.8% vs.Table 1. Summary of baseline and clinical characteristics of the patient
Parameters All patients
(n ¼ 57)
Demographic factor
Male, n (%) 30 (52.6)
Age (y)n 68.7713.7
Predisposing conditions for IAH, n (%)
Mechanical ventilation 10 (17.5)
Liver dysfunction 3 (5.3)
Positive ﬂuid balance 10 (17.5)
Ileus 15 (26.3)
Acidosis 6 (10.5)
Hypothermia 5 (8.8)
Polytransfusion 1 (1.8)
Coagulopathy 12 (21.1)
Sepsis 24 (42.1)
Shock 27 (47.4)
RIFLE (failure), n (%) 40 (70.2)
SAPS II scoren 44.9714.7
Mean CVP for initial 3 d (mmHg)† 9.7 (6.7–11.8)
Hb (g/dL)n 10.672.5
Baseline Cr (mg/dL)† 1.0 (0.9–1.7)
Urinary NGAL (ng/mL)† 173.3 (65.6–557.7)
Urinary L-FABP (ng/mL)† 19.1 (6.8–79.6)
Mean IAP (mmHg)n 22.879.6
IAP (mmHg), Day 1 (on admission)n 24.1710.7
IAP (mmHg), Day 2n 22.279.9
IAP (mmHg), Day 3n 21.7711.4
IAP: downtrend, n (%) 24 (42.1)
IAP: ﬂuctuation þ uptrend, n (%) 33 (57.9)
Clinical course
RRT, n (%) 26 (45.6)
Renal recovery on Day 7, n (%) 23 (40.4)
ICU length of stay (d)† 6.0 (3.0–11.0)
Length of hospital stay (d)† 15.0 (9.0–27.0)
In-hospital mortality, n (%) 12 (21.1)
n Mean7 SD.
† Median (interquartile range).
Cr, creatinine; CVP, central venous pressure; Hb, hemoglobin; IAH, intra-abd
unit; L-FABP, liver-type fatty acid binding protein; NGAL, neutrophil gelatinas
disease; RRT, renal replacement therapy; SAPS, simpliﬁed acute physiology85.3%, P ¼ 0.002), and a higher SAPS II score (39.97 12.0 vs.
48.27 15.5, P ¼ 0.035) were predictors of nonrecovery of
renal function, while the mean IAP, presence of IAH, or change
in IAP during the ﬁrst 3 days were not different between the
recovery and nonrecovery groups. Urinary NGAL (median
110.8 ng/mL vs. 239.2 ng/mL, P ¼ 0.050) and L-FABP at the
time of ICU admission (median 12.3 ng/mL vs. 20.7 ng/mL,
P ¼ 0.028) were also signiﬁcantly higher in the nonrecovery
group. To identify risk factors that independently predict renal
recovery from AKI, a multivariate analysis, which included
variables giving P values of o0.1 in univariate analysis, was
conducted. The presence of ileus, acidosis, sepsis, RIFLE cri-
teria, SAPS II score, hemoglobin, NGAL, and L-FABP were
included as variables in a binary logistic regression analysis
(backward method). Severe AKI [odds ratio (OR), 14.8], high
urinary NGAL level (OR, 1.015), and high urinary L-FABP level
(OR, 1.003) were found to be independent predictors of
nonrecovery (Table 2), but the presence of IAH was not (OR,
0.417; P ¼ 0.231).
We also evaluated and compared the diagnostic perfor-
mances of urinary biomarkers for predicting nonrecovery of
renal function by calculating the area under the receiver
operating characteristic (ROC) curves. Fig. 1 displays the ROC
curves of both urinary NGAL and FABP. Performance of urinary
L-FABP was better than that of NGAL (area under the curve,
0.700 vs. 0.681).s
IAH group Non-IAH group P
(n ¼ 45) (n ¼ 12)
21 (46.7) 9 (75.0) 0.081
68.6714.1 69.0712.5 0.929
8 (17.8) 2 (16.7) 0.928
2 (4.4) 1 (8.3) 0.592
10 (22.2) 0 (0.0) 0.072
12 (26.7) 3 (25.0) 0.790
5 (11.1) 1 (8.3) 0.781
5 (11.1) 0 (0.0) 0.227
1 (2.2) 0 (0.0) 0.602
11 (24.4) 1 (8.3) 0.224
21 (46.7) 3 (25.0) 0.177
23 (51.1) 4 (33.3) 0.273
31 (68.9) 9 (75.0) 0.681
44.8714.9 45.2714.6 0.940
10.6 (7.0–18.4) 8.5 (5.0–11.0) 0.138
10.772.7 10.372.0 0.635
0.9 (0.6–1.2) 1.8 (1.3–4.2) 0.044
210.2 (63.0–451.7) 347.5 (198.6–682.6) 0.314
26.5 (1.6–51.3) 20.7 (14.3–30.2) 0.826
25.678.4 12.275.6 <0.001
26.379.7 15.7711.0 0.002
25.279.6 9.975.2 <0.001
25.279.6 8.176.4 <0.001
17 (37.8) 7 (58.3) 0.200
28 (62.2) 5 (41.7)
19 (42.2) 7 (58.3) 0.319
20 (44.4) 3 (25.0) 0.223
5.5 (3.0–9.0) 5.0 (2.5–8.0) 0.479
13.0 (8.0–18.0) 14.0 (13.5–16.5) 0.638
10 (22.2) 2 (16.7) 0.675
ominal hypertension; IAP, intra-abdominal pressure; ICU, intensive care
e-associated lipocalin; RIFLE, risk–injury–failure–loss–end-stage kidney
score.
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In-hospital mortality was 21.1% in this study. Patients who did
not survive showed a signiﬁcantly higher prevalence of shock
(40% vs. 75%, P ¼ 0.031), lower hemoglobin levels (11.07 2.4 g/dL
vs. 9.27 2.8 g/dL, P ¼ 0.028), and higher SAPS II scores
(14.97 12.3 vs. 55.87 18.1, P ¼ 0.003) in univariate analysis.
We performed a multivariate logistic regression analysis to
identify factors that could predict in-hospital mortality, includ-
ing variables giving P values of o0.1 in univariate analysis.
Age, polytransfusion, shock, severe AKI (failure in RIFLE), SAPSure 1. Diagnostic performance of biomarker for predicting non-
covery from AKI, based on the calculation of the area under the
ceiver operating characteristic (ROC) curves. The area under the
C curves and the cutoff value of each urinary biomarker are
esented in a separate table below the ﬁgure. AKI, acute kidney injury;
C-ROC, area under the receiver operating characteristic curve; CI,
nﬁdence interval; L-FABP, liver-type fatty acid binding protein; NGAL,
utrophil gelatinase-associated lipocalin.
Table 2. Binary logistic regression analysis in predicting nonrecov-
ery of renal function from AKI in critically ill patients (backward
method)
Parameters OR 95% CI P
Urinary NGAL 1.015 1.000–1.006 0.018
Urinary L-FABP 1.003 1.000–1.030 0.006
RIFLE (failure) 14.8 2.250–97.060 0.001
Excluded variables: acidosis, age, hemoglobin, intra-abdominal hyper-
tension, intra-abdominal pressure on admission, ileus, polytransfusion,
Simpliﬁed Acute Physiology Score II, sepsis, and shock.
AKI, acute kidney injury; CI, conﬁdence interval; L-FABP, liver-type fatty
acid binding protein; NGAL, neutrophil gelatinase-associated lipocalin; OR,
odds ratio; RIFLE, risk–injury–failure–loss–end-stage kidney disease.II score, hemoglobin, urinary NGAL, and IAP on Day 1 were
included as variables in a binary logistic regression analysis
(backward method). In the ﬁnal model, after backward vari-
able selection, a high SAPS II score (OR, 1.102) and a high
urinary NGAL level (OR, 1.003) were shown to be independent
predictors of in-hospital mortality (Table 3). However, the
presence of IAH did not predict in-hospital mortality in
patients with established AKI (OR, 1.429; P ¼ 0.676). The
diagnostic performance of biomarkers for predicting in-
hospital mortality was analyzed and the cutoff value of urine
NGAL (248 ng/mL) was found to be able to predict mortality
with 77.8% sensitivity and 70.0% speciﬁcity (Fig. 2).Discussion
AKI is a signiﬁcant medical problem associated with poor
outcomes, including higher mortality, prolonged duration of
hospitalization, and increased risk of progression to chronic
kidney disease [15,16]. Therefore, predicting prognosis in patients
with established AKI is important to avoid unnecessary delays in
treatment and also exposure to nonbeneﬁcial management such
as excessive ﬂuid management or diuretics. However, no speciﬁc
predictive markers for renal recovery or mortality, or even a
standard deﬁnition of renal recovery, currently exist [17].
With the purpose of determining whether various para-
meters could predict renal recovery or mortality, weFigure 2. Diagnostic performance of urinary NGAL for predicting in-
hospital mortality in critically ill patients with AKI, based on the
calculation of the area under the receiver operating characteristic
(ROC) curves. The area under the ROC curves and the cutoff value of
each urinary biomarker are presented in a separate table below the
ﬁgure. AKI, acute kidney injury; AUC-ROC, area under the receiver
operating characteristic curve; CI, conﬁdence interval; NGAL, neutrophil
gelatinase-associated lipocalin.
Table 3. Binary logistic regression analysis in predicting in-hospital
mortality in critically ill patients with AKI (backward method)
Parameters OR 95% CI P
Urinary NGAL 1.003 1.000–1.006 0.024
SAPS II score 1.102 1.027–1.182 0.007
Excluded variables: acidosis, age, hemoglobin, intra-abdominal hyper-
tension, intra-abdominal pressure on admission, ileus, liver-type fatty
acid binding protein, polytransfusion, risk–injury–failure–loss–end-
stage kidney disease failure, sepsis, and shock.
CI, conﬁdence interval; NGAL, neutrophil gelatinase-associated lipoca-
lin; OR, odds ratio; SAPS, Simpliﬁed Acute Physiology Score.
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patients with established AKI who were admitted to the
medical ICU. We found that urinary NGAL, L-FABP, and failure
grade according to the RIFLE criteria were independent pre-
dictors of nonrecovery of renal function. Urinary NGAL and
SAPS II score were independent predictors of in-hospital
mortality. However, the presence of IAH was not found to be
useful in predicting either renal recovery or in-hospital mor-
tality in patients with established AKI.
As the abdominal cavity is considered a semiclosed com-
partment, any changes in its content may increase IAP [12,13].
According to the World Society of the Abdominal Compart-
ment Syndrome guidelines, IAH is deﬁned as a sustained or
repeated pathological elevation in IAP of Z12 mmHg, whereas
a sustained elevation of IAP of 420 mmHg, known as abdom-
inal compartment syndrome, is associated with organ dysfunc-
tion [9,12]. Elevation of IAP above physiological limits has
adverse effects on end-organ function, and the kidney is
especially vulnerable to IAH-induced organ dysfunction [18].
Recent data have indicated that IAH is emerging as an
important factor inﬂuencing AKI development in critically ill
patients [2–5,19]. Numerous conditions such as abdominal
surgery, severe pancreatitis, mechanical ventilation, sepsis,
ileus, and massive ﬂuid resuscitation are known risk factors
for IAH [12,13,20]. Increased renal venous pressure resulting
from IAH is thought to be directly responsible for renal
function impairment [1]. Sepsis syndrome, the most common
cause of admission to a medical ICU, requires massive ﬂuid
resuscitation to maintain hemodynamic stability, or mechan-
ical ventilation to treat combined pneumonia or adult respira-
tory distress syndrome. All these measures are likely to
increase IAH and can lead to the development of AKI in
critically ill patients [12,13,20].
Although incidence of IAH is known to be approximately
37–43% in critically ill ICU patients, or even higher in patients
who have two or more categorized risk factors for IAH (67.8%)
[12,13], the prevalence rate in our study, which included
patients with established AKI, was much higher (78.9%).
However, there was no association between the presence of
IAH and the severity of AKI. Because IAH was diagnosed after
AKI onset, a direct causal relationship between IAH and AKI
could not be determined. Instead, we tried to assess whether
the presence of IAH in patients with established AKI would
further compromise their outcome. We observed that the
presence of IAH in patients with AKI did not predict renal
recovery or in-hospital mortality. While data about the effect
of IAH on renal recovery are scarce, several studies have
demonstrated a relationship between IAH and mortality. In a
prospective cohort of 83 heterogeneous ICU patients, those
with IAH had signiﬁcantly higher mortality than those with noIAH (53% vs. 27%, P ¼ 0.02) [19]. However, in a larger study
comprising a mixed population of 265 critically ill patients
from 14 ICUs in six countries, Malbrain et al [13] found that
IAH on Day 1 did not predict mortality, a result consistent with
our ﬁndings. However, in another prospective cohort study of
151 medical ICUs, it was shown that patients with more than
two categorized risk factors for IAH (41.4% vs. 14.3%, Po0.001)
or nonresolution of IAH in the IAH group during their ICU stay
(64.7% vs. 35.7%, P ¼ 0.001) was associated with higher mor-
tality [12]. Further larger studies on measurement of IAP for
longer periods are needed to verify whether IAH can be used
to predict mortality.
Simultaneously, we also determined the prognostic value of
novel biomarkers, including NGAL and L-FABP, and that of the
RIFLE criteria or SAPS II in predicting the outcome of patients
with established AKI.
Since NGAL was ﬁrst introduced as a sensitive and speciﬁc
early marker of AKI, the utility of urinary NGAL as a predictive
or prognostic marker has been investigated extensively in
numerous patient groups with different characteristics [21].
Srisawat et al [22,23] have shown that plasma NGAL can predict
renal recovery from AKI following community-acquired pneu-
monia, and that urinary NGAL and hepatocyte growth factor can
predict renal recovery in critically ill patients with renal sup-
port. Our group also demonstrated that an initial NGAL was
useful in predicting mortality or renal recovery in patients with
AKI from mixed ICUs or general wards [24]. As expected, in this
study, we found that NGAL on ICU admission was useful to
predict both renal recovery and in-hospital mortality. A recent
study has shown that a gradual increment in urinary NGAL
appears superior to a single NGAL value in differentiating
between transient and sustained AKI on ICU admission [25].
Urine NGAL with a cutoff value of 248 ng/mL was found to
predict mortality with 77.8% sensitivity and 70.0% speciﬁcity.
However, urine L-FABP, another novel biomarker, was useful
in predicting only renal recovery, but not in-hospital mortality.
Yokoyama et al [26] reported that the amount of renal expres-
sion and urinary excretion of L-FABP signiﬁcantly reﬂected the
severity of tubulointerstitial damage. However, the results of
the current study do not concur with those of previous studies,
including ours, demonstrating the usefulness of L-FABP in
predicting 30-day or 90-day mortality in critically ill patients
[27,28]. Although it is not clear, these discrepancies between
the studies might be derived from the differences in baseline
characteristics of enrolled patients. In addition to initial urinary
NGAL and L-FABP, severe AKI (failure grade according to RIFLE
criteria) was also a good predictor of nonrecovery of renal
function. In deﬁning renal recovery, we used the following
criteria: serum creatinine level o0.45 mg/dL or within 20%
above the baseline value during hospitalization, without the
requirement for dialysis on Day 7. Twenty-three patients
(40.3%) showed renal recovery from AKI, but because the
deﬁnition of renal recovery and patient baseline characteristics
vary between studies, direct comparisons cannot be made.
Despite several meaningful ﬁndings, our study had some
limitations. First, the sample size was not large enough to
generalize these ﬁndings. Second, as IAP was measured only
for the ﬁrst 3 days, the effect of a changing pattern of IAP
during hospitalization could not be determined. However, IAP
should be measured daily during ICU admission for evaluating
it as a prognostic marker for AKI recovery, because IAP can
change according to therapy or patient status during admis-
sion. Therefore, further multicenter studies with longer follow-
Kidney Res Clin Pract 34 (2015) 103–108108up periods are needed to assess whether changes in IAP or its
resolution may affect the outcomes of patients with AKI.
In conclusion, we found that IAH was prevalent in critically
ill patients with established AKI. However, IAH on initial
admission did not predict short-term prognosis including
renal recovery or in-hospital mortality. Urinary NGAL was
found to be a useful predictor of both renal recovery and in-
hospital mortality. Large, multicenter prospective studies are
necessary to conﬁrm our results and validate the predictive
value of these factors for renal function recovery.Conﬂict of interest
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